Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
This piece helps you decide When To Allocate Funds To Debt Vs Emergency using a practical framework that balances growth and safety.
17,239 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
As brokerages race to attract new investors, free stock promotions are surging in March 2026. This report explains ho...
VR Adviser recently disclosed a substantial sale of Ocular Therapeutix shares, triggering questions about what it mea...
A wave of previously inaccessible BTC could re-enter markets in March, testing a fragile price zone and highlighting ...
A surge of optimism surrounds NVIDIA's latest driverless advances and what they mean for Uber stock investors. This p...
Gold back under $5,000 has traders weighing the next ETF move. This report compares key gold ETFs, costs, and what co...
The Treasury issued a general license for energy aboard vessels, unlocking up to 140 million barrels. Markets weigh t...
Interloom just raised $16.5 million to convert tacit knowledge into AI-driven workflow tools. The Munich startup says...
Kentucky lawmakers are advancing a consumer-protection bill tied to crypto kiosks that could force hardware wallet pr...
In a real-time test, we asked AI to pick the best crypto among Bitcoin, XRP, and Solana. The AI ranked Solana first, ...
A decade of dividend growth and a tiny fee have made the Vanguard Dividend Appreciation ETF a standout for risk-aware...
Solana looks poised at a crossroads as derivatives data shows a long-dominant tilt without fresh capital. The solana ...